Insider Transactions Reported by 20 Insiders of KYNTRA BIO, INC.

Symbol
KYNB on Nasdaq
Location
San Francisco, CA

Insiders trading volume in the past year

KYNTRA BIO, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rory B. Riggs Director $761,112 26 May 2021
Enrique A. Conterno Chief Executive Officer, Director $305,917 07 Jul 2023
Pat Cotroneo Executive Advisor & Former CFO $208,647 07 Sep 2021
Thomas F. Kearns Jr. Director $189,821 15 Sep 2021
Thane Wettig CEO, Director $182,833 +$84,413 +86% 06 Mar 2026
Mark Eisner EVP, Chief Medical Officer $121,537 06 Sep 2023
Christine Chung Svp, China Operations $115,012 06 Mar 2025
Deyaa Adib Chief Medical Officer $96,084 12 Jun 2024
Juan Graham Chief Financial Officer $56,400 06 Dec 2024
Gerald Lema Director $34,478 05 Jun 2024
David DeLucia Chief Financial Officer $33,128 06 Mar 2026
Kalevi Kurkijarvi Director $28,728 26 May 2021
Suzanne Blaug Director $22,491 05 Jun 2024
Jeffrey W. Henderson Director $21,938 01 Sep 2023
Benjamin Cravatt Director $21,839 05 Jun 2024
Aoife Brennan Director $21,240 05 Jun 2024
James A. Schoeneck Director $12,296 +$105,040 30 Jun 2025
Jeffrey L. Edwards Director 04 Jun 2025
Maykin Ho Director 04 Jun 2025
Michael Kauffman Director 04 Jun 2025

Recent Insider Transactions by Companies or Individuals for KYNTRA BIO, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Thane Wettig KYNB Common Stock Tax liability -1.12% -277 24,403 06 Mar 2026 Direct
David DeLucia KYNB Common Stock Tax liability -1.34% -60 4,429 06 Mar 2026 Direct
David DeLucia KYNB Stock Option (Right to Buy) Award 26,000 26,000 03 Feb 2026 Direct
Thane Wettig KYNB Stock Option (Right to Buy) Award 60,000 60,000 03 Feb 2026 Direct
David DeLucia FGEN Common Stock Tax liability -1.15% -52 4,489 06 Dec 2025 Direct
Thane Wettig FGEN Common Stock Tax liability -1.04% -259 24,680 06 Dec 2025 Direct
Thane Wettig FGEN Common Stock Purchase 12.1% $24,570 $9.10 2,700 24,939 17 Nov 2025 Direct
Thane Wettig FGEN Common Stock Purchase 4.71% $9,180 $9.18 1,000 22,239 13 Nov 2025 Direct
David DeLucia FGEN Common Stock Tax liability -1.15% -53 4,541 06 Sep 2025 Direct
Thane Wettig FGEN Common Stock Tax liability -1.15% -248 21,239 06 Sep 2025 Direct
James A. Schoeneck FGEN Common Stock Purchase 146.4% 23,567 39,666 30 Jun 2025 By Trust
David DeLucia FGEN Common Stock Tax liability -1.1% -51 4,594 06 Jun 2025 Direct
Thane Wettig FGEN Common Stock Tax liability -1.13% -246 21,487 06 Jun 2025 Direct
Maykin Ho FGEN Stock Option (Right to Buy) Award 120,000 120,000 04 Jun 2025 Direct
Jeffrey L. Edwards FGEN Stock Option (Right to Buy) Award 120,000 120,000 04 Jun 2025 Direct
James A. Schoeneck FGEN Stock Option (Right to Buy) Award 120,000 120,000 04 Jun 2025 Direct
Michael Kauffman FGEN Stock Option (Right to Buy) Award 190,000 120,000 04 Jun 2025 Direct
Thane Wettig FGEN Common Stock Purchase 36.4% $50,663 $0.3494 145,000 543,329 24 Mar 2025 Direct
James A. Schoeneck FGEN Common Stock Purchase 15.4% $17,040 $0.3408 50,000 373,722 21 Mar 2025 By Trust
James A. Schoeneck FGEN Common Stock Purchase 339.1% $88,000 $0.3520 250,000 323,722 20 Mar 2025 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.